APO Research, Inc.

APO RESEARCH · REPORT

Hemostatic Forceps

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

Product & engineering

Understand the product.

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.

Selected research

Market Structure

Global Hemostatic Forceps Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.

For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.

Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.

Read the full market overview

North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.

In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.

This report provides an overview of the global Hemostatic Forceps market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostatic Forceps and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostatic Forceps sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostatic Forceps market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostatic Forceps Segment by Company

Medline

B. Braun

CareFusion

Asa Dental

Sklar

Scanlan International

Shanghai Medical Instruments

Lawton

Hu-Friedy

Xinhua Surgical

Towne Brothers

Teleflex Medical

Delacroix Chevalier

YDM

M A Corporation

MedGyn Products

Inami

Ted Pella

Medicon eG

J & J Instruments

American Diagnostic

Hemostatic Forceps Segment by Type

Halstead Mosquito Hemostatic Forceps

Kelly and Crile Hemostatic Forceps

Rochester-Carmalt Hemostatic Forceps

Hemostatic Forceps Segment by Application

Surgical

Dissection

Dental

Laparoscopic

Others

Hemostatic Forceps Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Forceps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Forceps and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Forceps.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostatic Forceps market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostatic Forceps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemostatic Forceps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemostatic Forceps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemostatic Forceps Industry Trends Table 2. Hemostatic Forceps Industry Drivers Table 3. Hemostatic Forceps Industry Opportunities and Challenges Table 4. Hemostatic Forceps Industry Restraints Table 5. Global Hemostatic Forceps Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemostatic Forceps Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemostatic Forceps Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hemostatic Forceps Sales Market Share by Manufacturers Table 9. Global Hemostatic Forceps Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Hemostatic Forceps Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemostatic Forceps Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemostatic Forceps Manufacturers, Product Type & Application Table 13. Global Hemostatic Forceps Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostatic Forceps by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Halstead Mosquito Hemostatic Forceps Table 17. Major Manufacturers of Kelly and Crile Hemostatic Forceps Table 18. Major Manufacturers of Rochester-Carmalt Hemostatic Forceps Table 19. Global Hemostatic Forceps Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hemostatic Forceps Sales by Type (2021-2026) & (K Units) Table 21. Global Hemostatic Forceps Sales by Type (2027-2032) & (K Units) Table 22. Global Hemostatic Forceps Sales Market Share by Type (2021-2026) Table 23. Global Hemostatic Forceps Sales Market Share by Type (2027-2032) Table 24. Global Hemostatic Forceps Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Hemostatic Forceps Revenue by Type (2021-2026) & (K Units) Table 26. Global Hemostatic Forceps Revenue by Type (2027-2032) & (K Units) Table 27. Global Hemostatic Forceps Revenue Market Share by Type (2021-2026) Table 28. Global Hemostatic Forceps Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Surgical Table 30. Major Manufacturers of Dissection Table 31. Major Manufacturers of Dental Table 32. Major Manufacturers of Laparoscopic Table 33. Major Manufacturers of Others Table 34. Global Hemostatic Forceps Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Hemostatic Forceps Sales by Application (2021-2026) & (K Units) Table 36. Global Hemostatic Forceps Sales by Application (2027-2032) & (K Units) Table 37. Global Hemostatic Forceps Sales Market Share by Application (2021-2026) Table 38. Global Hemostatic Forceps Sales Market Share by Application (2027-2032) Table 39. Global Hemostatic Forceps Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Hemostatic Forceps Revenue by Application (2021-2026) & (K Units) Table 41. Global Hemostatic Forceps Revenue by Application (2027-2032) & (K Units) Table 42. Global Hemostatic Forceps Revenue Market Share by Application (2021-2026) Table 43. Global Hemostatic Forceps Revenue Market Share by Application (2027-2032) Table 44. Global Hemostatic Forceps Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Hemostatic Forceps Sales by Region (2021-2026) & (K Units) Table 46. Global Hemostatic Forceps Sales Market Share by Region (2021-2026) Table 47. Global Hemostatic Forceps Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Hemostatic Forceps Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 51. North America Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 52. Europe Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 54. Europe Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Hemostatic Forceps Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Hemostatic Forceps Sales by Country (2027-2032) & (K Units) Table 61. Global Hemostatic Forceps Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Hemostatic Forceps Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Hemostatic Forceps Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Hemostatic Forceps Revenue Market Share by Region (2021-2026) Table 65. Global Hemostatic Forceps Revenue Market Share by Region (2027-2032) Table 66. Medline Company Information Table 67. Medline Business Overview Table 68. Medline Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Medline Hemostatic Forceps Product Portfolio Table 70. Medline Recent Development Table 71. B. Braun Company Information Table 72. B. Braun Business Overview Table 73. B. Braun Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. B. Braun Hemostatic Forceps Product Portfolio Table 75. B. Braun Recent Development Table 76. CareFusion Company Information Table 77. CareFusion Business Overview Table 78. CareFusion Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. CareFusion Hemostatic Forceps Product Portfolio Table 80. CareFusion Recent Development Table 81. Asa Dental Company Information Table 82. Asa Dental Business Overview Table 83. Asa Dental Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Asa Dental Hemostatic Forceps Product Portfolio Table 85. Asa Dental Recent Development Table 86. Sklar Company Information Table 87. Sklar Business Overview Table 88. Sklar Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sklar Hemostatic Forceps Product Portfolio Table 90. Sklar Recent Development Table 91. Scanlan International Company Information Table 92. Scanlan International Business Overview Table 93. Scanlan International Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Scanlan International Hemostatic Forceps Product Portfolio Table 95. Scanlan International Recent Development Table 96. Shanghai Medical Instruments Company Information Table 97. Shanghai Medical Instruments Business Overview Table 98. Shanghai Medical Instruments Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Shanghai Medical Instruments Hemostatic Forceps Product Portfolio Table 100. Shanghai Medical Instruments Recent Development Table 101. Lawton Company Information Table 102. Lawton Business Overview Table 103. Lawton Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Lawton Hemostatic Forceps Product Portfolio Table 105. Lawton Recent Development Table 106. Hu-Friedy Company Information Table 107. Hu-Friedy Business Overview Table 108. Hu-Friedy Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Hu-Friedy Hemostatic Forceps Product Portfolio Table 110. Hu-Friedy Recent Development Table 111. Xinhua Surgical Company Information Table 112. Xinhua Surgical Business Overview Table 113. Xinhua Surgical Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Xinhua Surgical Hemostatic Forceps Product Portfolio Table 115. Xinhua Surgical Recent Development Table 116. Towne Brothers Company Information Table 117. Towne Brothers Business Overview Table 118. Towne Brothers Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Towne Brothers Hemostatic Forceps Product Portfolio Table 120. Towne Brothers Recent Development Table 121. Teleflex Medical Company Information Table 122. Teleflex Medical Business Overview Table 123. Teleflex Medical Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Teleflex Medical Hemostatic Forceps Product Portfolio Table 125. Teleflex Medical Recent Development Table 126. Delacroix Chevalier Company Information Table 127. Delacroix Chevalier Business Overview Table 128. Delacroix Chevalier Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Delacroix Chevalier Hemostatic Forceps Product Portfolio Table 130. Delacroix Chevalier Recent Development Table 131. YDM Company Information Table 132. YDM Business Overview Table 133. YDM Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. YDM Hemostatic Forceps Product Portfolio Table 135. YDM Recent Development Table 136. M A Corporation Company Information Table 137. M A Corporation Business Overview Table 138. M A Corporation Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. M A Corporation Hemostatic Forceps Product Portfolio Table 140. M A Corporation Recent Development Table 141. MedGyn Products Company Information Table 142. MedGyn Products Business Overview Table 143. MedGyn Products Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. MedGyn Products Hemostatic Forceps Product Portfolio Table 145. MedGyn Products Recent Development Table 146. Inami Company Information Table 147. Inami Business Overview Table 148. Inami Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Inami Hemostatic Forceps Product Portfolio Table 150. Inami Recent Development Table 151. Ted Pella Company Information Table 152. Ted Pella Business Overview Table 153. Ted Pella Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Ted Pella Hemostatic Forceps Product Portfolio Table 155. Ted Pella Recent Development Table 156. Medicon eG Company Information Table 157. Medicon eG Business Overview Table 158. Medicon eG Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Medicon eG Hemostatic Forceps Product Portfolio Table 160. Medicon eG Recent Development Table 161. J & J Instruments Company Information Table 162. J & J Instruments Business Overview Table 163. J & J Instruments Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. J & J Instruments Hemostatic Forceps Product Portfolio Table 165. J & J Instruments Recent Development Table 166. American Diagnostic Company Information Table 167. American Diagnostic Business Overview Table 168. American Diagnostic Hemostatic Forceps Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. American Diagnostic Hemostatic Forceps Product Portfolio Table 170. American Diagnostic Recent Development Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Hemostatic Forceps Distributors List Table 174. Hemostatic Forceps Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Hemostatic Forceps Product Image Figure 2. Global Hemostatic Forceps Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatic Forceps Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostatic Forceps Sales (2021-2032) & (K Units) Figure 5. Global Hemostatic Forceps Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemostatic Forceps Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Halstead Mosquito Hemostatic Forceps Image Figure 9. Kelly and Crile Hemostatic Forceps Image Figure 10. Rochester-Carmalt Hemostatic Forceps Image Figure 11. Global Hemostatic Forceps Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Hemostatic Forceps Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Hemostatic Forceps Sales Market Share by Type (2021-2032) Figure 14. Global Hemostatic Forceps Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Hemostatic Forceps Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Hemostatic Forceps Revenue Market Share by Type (2021-2032) Figure 17. Surgical Image Figure 18. Dissection Image Figure 19. Dental Image Figure 20. Laparoscopic Image Figure 21. Others Image Figure 22. Global Hemostatic Forceps Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hemostatic Forceps Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Hemostatic Forceps Sales Market Share by Application (2021-2032) Figure 25. Global Hemostatic Forceps Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Hemostatic Forceps Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Hemostatic Forceps Revenue Market Share by Application (2021-2032) Figure 28. North America Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 30. U.S. Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 35. Germany Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 42. China Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Hemostatic Forceps Sales Market Share by Country (2021-2032) Figure 50. Brazil Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Hemostatic Forceps Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Hemostatic Forceps Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Hemostatic Forceps Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Hemostatic Forceps Revenue (2021-2032) & (US$ Million) Figure 61. North America Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Hemostatic Forceps Revenue (2021-2032) & (US$ Million) Figure 63. Europe Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Hemostatic Forceps Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Hemostatic Forceps Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Hemostatic Forceps Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Hemostatic Forceps Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Halstead Mosquito Hemostatic Forceps
  • Kelly and Crile Hemostatic Forceps
  • Rochester-Carmalt Hemostatic Forceps
Applications
  • Surgical
  • Dissection
  • Dental
  • Laparoscopic
  • Others
Companies covered
  • Medline
  • B. Braun
  • CareFusion
  • Asa Dental
  • Sklar
  • Scanlan International
  • Shanghai Medical Instruments
  • Lawton
  • Hu-Friedy
  • Xinhua Surgical
  • Towne Brothers
  • Teleflex Medical
  • Delacroix Chevalier
  • YDM
  • M A Corporation
  • MedGyn Products
  • Inami
  • Ted Pella
  • Medicon eG
  • J & J Instruments
  • American Diagnostic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemostatic Forceps Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemostatic Forceps Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemostatic Forceps Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemostatic Forceps Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemostatic Forceps Market Dynamics
  1. 2.1 Hemostatic Forceps Industry Trends
  2. 2.2 Hemostatic Forceps Industry Drivers
  3. 2.3 Hemostatic Forceps Industry Opportunities and Challenges
  4. 2.4 Hemostatic Forceps Industry Restraints
3 Hemostatic Forceps Market by Manufacturers
  1. 3.1 Global Hemostatic Forceps Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemostatic Forceps Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemostatic Forceps Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemostatic Forceps Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostatic Forceps Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemostatic Forceps Manufacturers, Product Type & Application
  7. 3.7 Global Hemostatic Forceps Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostatic Forceps Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostatic Forceps Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostatic Forceps Tier 1, Tier 2, and Tier 3
4 Hemostatic Forceps Market by Type
  1. 4.1 Hemostatic Forceps Type Introduction
  2. 4.1.1 Halstead Mosquito Hemostatic Forceps
  3. 4.1.2 Kelly and Crile Hemostatic Forceps
  4. 4.1.3 Rochester-Carmalt Hemostatic Forceps
  5. 4.2 Global Hemostatic Forceps Sales by Type
  6. 4.2.1 Global Hemostatic Forceps Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hemostatic Forceps Sales by Type (2021-2032)
  8. 4.2.3 Global Hemostatic Forceps Sales Market Share by Type (2021-2032)
  9. 4.3 Global Hemostatic Forceps Revenue by Type
  10. 4.3.1 Global Hemostatic Forceps Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hemostatic Forceps Revenue by Type (2021-2032)
  12. 4.3.3 Global Hemostatic Forceps Revenue Market Share by Type (2021-2032)
5 Hemostatic Forceps Market by Application
  1. 5.1 Hemostatic Forceps Application Introduction
  2. 5.1.1 Surgical
  3. 5.1.2 Dissection
  4. 5.1.3 Dental
  5. 5.1.4 Laparoscopic
  6. 5.1.5 Others
  7. 5.2 Global Hemostatic Forceps Sales by Application
  8. 5.2.1 Global Hemostatic Forceps Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hemostatic Forceps Sales by Application (2021-2032)
  10. 5.2.3 Global Hemostatic Forceps Sales Market Share by Application (2021-2032)
  11. 5.3 Global Hemostatic Forceps Revenue by Application
  12. 5.3.1 Global Hemostatic Forceps Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hemostatic Forceps Revenue by Application (2021-2032)
  14. 5.3.3 Global Hemostatic Forceps Revenue Market Share by Application (2021-2032)
6 Global Hemostatic Forceps Sales by Region
  1. 6.1 Global Hemostatic Forceps Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostatic Forceps Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostatic Forceps Sales by Region (2021-2026)
  4. 6.2.2 Global Hemostatic Forceps Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemostatic Forceps Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemostatic Forceps Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemostatic Forceps Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemostatic Forceps Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemostatic Forceps Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemostatic Forceps Revenue by Region
  1. 7.1 Global Hemostatic Forceps Revenue by Region
  2. 7.1.1 Global Hemostatic Forceps Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemostatic Forceps Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemostatic Forceps Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemostatic Forceps Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemostatic Forceps Revenue (2021-2032)
  8. 7.2.2 North America Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemostatic Forceps Revenue (2021-2032)
  11. 7.3.2 Europe Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemostatic Forceps Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemostatic Forceps Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemostatic Forceps Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medline
  2. 8.1.1 Medline Company Information
  3. 8.1.2 Medline Business Overview
  4. 8.1.3 Medline Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medline Hemostatic Forceps Product Portfolio
  6. 8.1.5 Medline Recent Developments
  7. 8.2 B. Braun
  8. 8.2.1 B. Braun Company Information
  9. 8.2.2 B. Braun Business Overview
  10. 8.2.3 B. Braun Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 B. Braun Hemostatic Forceps Product Portfolio
  12. 8.2.5 B. Braun Recent Developments
  13. 8.3 CareFusion
  14. 8.3.1 CareFusion Company Information
  15. 8.3.2 CareFusion Business Overview
  16. 8.3.3 CareFusion Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CareFusion Hemostatic Forceps Product Portfolio
  18. 8.3.5 CareFusion Recent Developments
  19. 8.4 Asa Dental
  20. 8.4.1 Asa Dental Company Information
  21. 8.4.2 Asa Dental Business Overview
  22. 8.4.3 Asa Dental Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Asa Dental Hemostatic Forceps Product Portfolio
  24. 8.4.5 Asa Dental Recent Developments
  25. 8.5 Sklar
  26. 8.5.1 Sklar Company Information
  27. 8.5.2 Sklar Business Overview
  28. 8.5.3 Sklar Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sklar Hemostatic Forceps Product Portfolio
  30. 8.5.5 Sklar Recent Developments
  31. 8.6 Scanlan International
  32. 8.6.1 Scanlan International Company Information
  33. 8.6.2 Scanlan International Business Overview
  34. 8.6.3 Scanlan International Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Scanlan International Hemostatic Forceps Product Portfolio
  36. 8.6.5 Scanlan International Recent Developments
  37. 8.7 Shanghai Medical Instruments
  38. 8.7.1 Shanghai Medical Instruments Company Information
  39. 8.7.2 Shanghai Medical Instruments Business Overview
  40. 8.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
  42. 8.7.5 Shanghai Medical Instruments Recent Developments
  43. 8.8 Lawton
  44. 8.8.1 Lawton Company Information
  45. 8.8.2 Lawton Business Overview
  46. 8.8.3 Lawton Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lawton Hemostatic Forceps Product Portfolio
  48. 8.8.5 Lawton Recent Developments
  49. 8.9 Hu-Friedy
  50. 8.9.1 Hu-Friedy Company Information
  51. 8.9.2 Hu-Friedy Business Overview
  52. 8.9.3 Hu-Friedy Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
  54. 8.9.5 Hu-Friedy Recent Developments
  55. 8.10 Xinhua Surgical
  56. 8.10.1 Xinhua Surgical Company Information
  57. 8.10.2 Xinhua Surgical Business Overview
  58. 8.10.3 Xinhua Surgical Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
  60. 8.10.5 Xinhua Surgical Recent Developments
  61. 8.11 Towne Brothers
  62. 8.11.1 Towne Brothers Company Information
  63. 8.11.2 Towne Brothers Business Overview
  64. 8.11.3 Towne Brothers Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
  66. 8.11.5 Towne Brothers Recent Developments
  67. 8.12 Teleflex Medical
  68. 8.12.1 Teleflex Medical Company Information
  69. 8.12.2 Teleflex Medical Business Overview
  70. 8.12.3 Teleflex Medical Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
  72. 8.12.5 Teleflex Medical Recent Developments
  73. 8.13 Delacroix Chevalier
  74. 8.13.1 Delacroix Chevalier Company Information
  75. 8.13.2 Delacroix Chevalier Business Overview
  76. 8.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
  78. 8.13.5 Delacroix Chevalier Recent Developments
  79. 8.14 YDM
  80. 8.14.1 YDM Company Information
  81. 8.14.2 YDM Business Overview
  82. 8.14.3 YDM Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 YDM Hemostatic Forceps Product Portfolio
  84. 8.14.5 YDM Recent Developments
  85. 8.15 M A Corporation
  86. 8.15.1 M A Corporation Company Information
  87. 8.15.2 M A Corporation Business Overview
  88. 8.15.3 M A Corporation Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 M A Corporation Hemostatic Forceps Product Portfolio
  90. 8.15.5 M A Corporation Recent Developments
  91. 8.16 MedGyn Products
  92. 8.16.1 MedGyn Products Company Information
  93. 8.16.2 MedGyn Products Business Overview
  94. 8.16.3 MedGyn Products Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
  96. 8.16.5 MedGyn Products Recent Developments
  97. 8.17 Inami
  98. 8.17.1 Inami Company Information
  99. 8.17.2 Inami Business Overview
  100. 8.17.3 Inami Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Inami Hemostatic Forceps Product Portfolio
  102. 8.17.5 Inami Recent Developments
  103. 8.18 Ted Pella
  104. 8.18.1 Ted Pella Company Information
  105. 8.18.2 Ted Pella Business Overview
  106. 8.18.3 Ted Pella Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Ted Pella Hemostatic Forceps Product Portfolio
  108. 8.18.5 Ted Pella Recent Developments
  109. 8.19 Medicon eG
  110. 8.19.1 Medicon eG Company Information
  111. 8.19.2 Medicon eG Business Overview
  112. 8.19.3 Medicon eG Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Medicon eG Hemostatic Forceps Product Portfolio
  114. 8.19.5 Medicon eG Recent Developments
  115. 8.20 J & J Instruments
  116. 8.20.1 J & J Instruments Company Information
  117. 8.20.2 J & J Instruments Business Overview
  118. 8.20.3 J & J Instruments Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
  120. 8.20.5 J & J Instruments Recent Developments
  121. 8.21 American Diagnostic
  122. 8.21.1 American Diagnostic Company Information
  123. 8.21.2 American Diagnostic Business Overview
  124. 8.21.3 American Diagnostic Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
  126. 8.21.5 American Diagnostic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostatic Forceps Value Chain Analysis
  2. 9.1.1 Hemostatic Forceps Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostatic Forceps Production Mode & Process
  6. 9.2 Hemostatic Forceps Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostatic Forceps Distributors
  9. 9.2.3 Hemostatic Forceps Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.